The allure of wearable activity trackers has captured the attention of parents and health professionals alike. These devices promise to encourage physical activity in young people, but does the evidence support these claims? This systematic review and meta-analysis delves into the world of wearable trackers to assess their impact on daily steps and moderate-to-vigorous physical activity (MVPA) in children and adolescents. Our findings reveal insights into the effectiveness of these devices in promoting a healthier lifestyle for the next generation.
Physical inactivity is a growing concern among children and adolescents, contributing to a host of health issues. Wearable activity trackers have emerged as potential tools to combat this problem by providing real-time feedback on physical activity levels. While these devices have gained popularity, their efficacy in promoting sustained behavior change remains unclear. This study aims to systematically evaluate the evidence on the impact of wearable activity trackers on physical activity in young people.
We conducted a comprehensive search of four major databases for randomized controlled trials and clustered randomized controlled trials investigating the effects of wearable activity trackers on physical activity in children and adolescents. Data on participant characteristics, intervention details, and outcome measures were extracted and pooled using meta-analysis.
Our analysis included 21 studies involving over 3600 participants. While wearable activity trackers significantly increased daily step counts, their effect on MVPA was less pronounced. Heterogeneity between studies was evident, suggesting that factors such as intervention design, participant characteristics, and outcome measures influence the effectiveness of these devices.
The findings of this study indicate that wearable activity trackers can be a valuable tool for increasing daily steps in children and adolescents. However, their impact on MVPA, a crucial component of physical fitness, is less clear. Future research should explore the factors that contribute to the variability in study results and investigate the long-term effects of these devices.
Wearable activity trackers show promise in promoting physical activity among young people, particularly in terms of increasing daily step counts. However, their role in fostering sustained behavior change and improving overall health requires further investigation. To maximize the benefits of these devices, tailored interventions that combine wearable technology with other behavior change strategies may be necessary.
Au WW, Recchia F, Fong DY, et al. Effect of wearable activity trackers on physical activity in children and adolescents: a systematic review and meta-analysis. Lancet Digit Health. Published online August 6, 2024. doi:10.1016/S2589-7500(24)00139-0
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation